This is a proposal for a Tissue Culture and Immunoassay Core (TCIC) facility which purpose is to provide a centralized resource for cell culture maintenance, cellular and viral purification, and immunoassay performance, in support for four projects included in the Allergic Disease Center (AADRC) at University of Texas Medical Branch (UTMB). Specific objectives of the TCIC to provide infrastructure necessary to: 1. Maintain a tissue bank of human cell lines (mostly of epithelial origin); 2. Routinely isolate blood eosinophils from normal, non-allergic donors; 3. Prepare pools of sucrose-purified respiratory synctial virus; 4. Perform ELISAs for human and mouse cytokines/chemokines. The support of the TCIC facility is justified because of the critical need for a number of biological reagents, methodological procedures and immunological assays, common to all four projects of the AADRC. In addition, centralized acquisition of reagents and performance of the tests will minimize the cost of M&O and personnel for the whole center and will result in an optimal standardization of assays and experimental procedures. The proposed TCIC facility will take advantage of some resources currently available to the AADRC investigators at UTMB, including the Child Health Research Center (CHRC) laboratory, a 4,000 ft/2, state-of-the-art laboratory facility where the TCIC will be physically located. The central location of the TCIC within the UTMB campus will facilitate the communications among the different investigators of the AADRC resulting in a more efficient and timely completion of the proposed research.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Texas Medical Br Galveston
United States
Zip Code
Welliver, Timothy P; Reed, Jennifer L; Welliver Sr, Robert C (2008) Respiratory syncytial virus and influenza virus infections: observations from tissues of fatal infant cases. Pediatr Infect Dis J 27:S92-6
Garofalo, Roberto P; Hintz, Karen H; Hill, Vanessa et al. (2005) A comparison of epidemiologic and immunologic features of bronchiolitis caused by influenza virus and respiratory syncytial virus. J Med Virol 75:282-9
Bacsi, Attila; Dharajiya, Nilesh; Choudhury, Barun K et al. (2005) Effect of pollen-mediated oxidative stress on immediate hypersensitivity reactions and late-phase inflammation in allergic conjunctivitis. J Allergy Clin Immunol 116:836-43
Boldogh, Istvan; Bacsi, Attila; Choudhury, Barun K et al. (2005) ROS generated by pollen NADPH oxidase provide a signal that augments antigen-induced allergic airway inflammation. J Clin Invest 115:2169-79
Garofalo, Roberto P; Hintz, Karen H; Hill, Vanessa et al. (2004) Production of interferon gamma in respiratory syncytial virus infection of humans is not associated with interleukins 12 and 18. J Med Virol 73:289-94
Haeberle, Helene A; Casola, Antonella; Gatalica, Zoran et al. (2004) IkappaB kinase is a critical regulator of chemokine expression and lung inflammation in respiratory syncytial virus infection. J Virol 78:2232-41
Gorska, Magdalena M; Stafford, Susan J; Cen, Osman et al. (2004) Unc119, a novel activator of Lck/Fyn, is essential for T cell activation. J Exp Med 199:369-79
Adachi, Tetsuya; Stafford, Susan; Kayaba, Hiroyuki et al. (2003) Myosin light chain kinase mediates eosinophil chemotaxis in a mitogen-activated protein kinase-dependent manner. J Allergy Clin Immunol 111:113-6
Leonard, Patricia; Sur, Sanjiv (2003) Interleukin-12: potential role in asthma therapy. BioDrugs 17:1-7
Cen, Osman; Gorska, Magdalena M; Stafford, Susan J et al. (2003) Identification of UNC119 as a novel activator of SRC-type tyrosine kinases. J Biol Chem 278:8837-45

Showing the most recent 10 out of 20 publications